Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-glutamyltransferase light chain 1 (GGTLC1) is a protein encoded by the GGTLC1 gene. It is a member of the gamma-glutamyl transpeptidase (GGT) family but is distinct from the better-studied GGT1 enzyme. GGTLC1 contains homology to the light chain region of canonical GGT enzymes but lacks a transmembrane domain and the full enzymatic activity found in classical GGTs. Its function is incompletely understood; Gene Ontology descriptions list its gamma-glutamyltransferase activity as "obsolete," and its characterized physiological roles and interacting drugs remain unknown. Disease associations are limited, with possible links to glutathionuria, but no direct evidence establishes it as a therapeutic target. Key context: - GGTLC1 is not the canonical gamma-glutamyltransferase 1 (GGT1) enzyme, which is well-characterized and therapeutically relevant as a biomarker and in glutathione metabolism. - The protein encoded by GGTLC1 is more limited in function, with uncertain or non-established enzymatic activity. - Multiple aliases exist because of historical naming in different studies; however, GGTLC1 is specific and not the main enzymatic target in this gene family. - There are no drugs, mechanisms of action, or biomarker data associated with GGTLC1. Note: This target is frequently confused with "gamma-glutamyltransferase 1" (GGT1), which *is* a validated enzyme and significant therapeutic target involved in glutathione metabolism, drug resistance in cancer, and is a clinical biomarker. Your target, however, is GGTLC1, which does not currently fit these criteria, and its therapeutic relevance is not established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-glutamyltransferase light chain 1 (GGTLC1).